english.prescrire.org > Spotlight > 100 most recent

Spotlight

Every month, the subjects in Prescrire’s Spotlight.

100 most recent :  1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90

A difficult choice

Anifrolumab (Saphnelo°) in systemic lupus erythematosus after failure of standard therapy

Dabigatran (Pradaxa°) for venous thrombosis in children and adolescents

Janus kinase inhibitors: higher incidence of serious adverse effects and death than with TNF-alpha inhibitors

Dutasteride, finasteride: high-grade prostate cancer (continued)

Order of magnitude

Prescrire's ratings of new drugs in 2022

Belimumab (Benlysta°) in lupus nephritis

Omicron variant BQ.1.1: nirmatrelvir + ritonavir retains activity, monoclonal antibodies do not

Ibrutinib: increased risk of sudden death

1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90